SCHEMBL15941192

SCHEMBL15941192

O=C(CC(=O)c1ccc2occc2c1)c1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 9/20 0.83
WNT3A P56704 9/20 0.83
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
KDM4E B2RXH2 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
CES1 P23141 1/20 0.53
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
IDO1 P14902 3/20 0.52
HTR1B P28222 1/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP1B1 Q16678 1/20 0.51
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15968867 0.91 CTNNB1 (1.00) CTNNB1WNT3ASMN1; SMN2IDO1HTR1B
SCHEMBL13736985 0.87 CTNNB1 (0.68) CTNNB1WNT3AIDO1HTR1BNAMPT
SCHEMBL21980371 0.85 CTNNB1 (0.62) CTNNB1WNT3AIDO1HTR1BNAMPT
SCHEMBL1602054 0.82 CTNNB1 (0.69) CTNNB1WNT3AMEN1KMT2AKDM4E
SCHEMBL12532344 0.81 CTNNB1 (0.57) CTNNB1WNT3AMEN1KMT2AKDM4E
SCHEMBL13516717 0.80 CTNNB1 (0.61) CTNNB1WNT3AMEN1KMT2AIDO1
SCHEMBL30791009 0.80 CTNNB1 (0.61) CTNNB1WNT3AMEN1KMT2AIDO1
SCHEMBL2254908 0.79 CTNNB1 (0.68) CTNNB1WNT3AMAPTSMN1; SMN2IDO1
SCHEMBL1691662 0.79 CTNNB1 (0.65) CTNNB1WNT3AHTR1BNAMPTTAS1R3
SCHEMBL24111717 0.78 CTNNB1 (0.62) CTNNB1WNT3AIDO1HTR1BNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108024950-B Method for enriching phellinus igniarius seed element of karanja oil 碧昂赛恩斯公司 2021-05-11 CN claimed
EP-3598999-A1 METHOD FOR ENRICHING KARANJA OIL Biosynthis (FR) 2020-01-29 EP claimed
EP-3325103-B1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL BIOSYNTHIS SARL (FR) 2019-09-11 EP claimed
US-10245220-B2 Process for pongamol enrichment of karanja oil BIOSYNTHIS (FR) 2019-04-02 US claimed
US-20180207070-A1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL BIOSYNTHIS (FR) 2018-07-26 US claimed
EP-3325103-A1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL Biosynthis (FR) 2018-05-30 EP claimed
CN-108024950-A Method for the Indian beech seed element enrichment of Ka Lanjia oil 碧昂赛恩斯公司 2018-05-11 CN claimed
WO-2017013264-A1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL BIOSYNTHIS (FR) 2017-01-26 WO claimed
WO-2016044768-A1 COMPOSITIONS, METHODS, PACKAGING AND APPARATUS TO ENHANCE SOIL FERTILITY AND PLANT GROWTH GLOBAL SOIL SOLUTIONS, INC. (US) 2016-03-24 WO claimed
US-20250367107-A1 SUNSCREEN COMPOSITION INCLUDING A SALICYLATE AND PONGAMIA PINNATA SEED EXTRACT EDGEWELL PERSONAL CARE BRANDS LLC (US) 2025-12-04 US disclosed
EP-3466930-B1 REDUCED SODIUM FOOD PRODUCT GEN MILLS INC (US) 2022-07-20 EP disclosed
CN-108024950-B Method for enriching phellinus igniarius seed element of karanja oil 碧昂赛恩斯公司 2021-05-11 CN disclosed
CN-108024950-B Method for enriching phellinus igniarius seed element of karanja oil 碧昂赛恩斯公司 2021-05-11 CN disclosed
US-20200281236-A1 REDUCED SODIUM FOOD PRODUCTS GEN MILLS INC (US) 2020-09-10 US disclosed
WO-2014124198-A1 REDUCED SODIUM FOOD PRODUCT GENERAL MILLS, INC. (US) 2014-08-14 WO disclosed
WO-2014124207-A1 REDUCED SODIUM FOOD PRODUCTS GENERAL MILLS, INC. (US) 2014-08-14 WO disclosed
WO-2014124205-A1 REDUCED SODIUM FOOD PRODUCTS GENERAL MILLS, INC. (US) 2014-08-14 WO disclosed
WO-2014124209-A1 REDUCED SODIUM FOOD PRODUCTS GENERAL MILLS, INC. (US) 2014-08-14 WO disclosed
WO-2014124220-A1 REDUCED SODIUM FOOD PRODUCT GENERAL MILLS, INC. (US) 2014-08-14 WO disclosed
WO-2014124193-A1 REDUCED SODIUM FOOD PRODUCTS GENERAL MILLS, INC. (US) 2014-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10245220-B2 Process for pongamol enrichment of karanja oil CBX3, PAOX, CBX8 CTNNB1 2197/4885WNT3A 3463/4885MEN1 4312/4885
US-20180207070-A1 PROCESS FOR PONGAMOL ENRICHMENT OF KARANJA OIL CBX3, PAOX, CBX8 CTNNB1 2197/4885WNT3A 3463/4885MEN1 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.